Location History:
- Saint Gratien, FR (2012)
- Sannois, FR (2017 - 2020)
Company Filing History:
Years Active: 2012-2020
Title: Jean-Christophe Bouthegourd: Innovator in Veterinary Epilepsy Treatments
Introduction
Jean-Christophe Bouthegourd is a notable inventor based in Sannois, France. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of epilepsy in animals. With a total of three patents, his work emphasizes the use of medium chain triglycerides (MCTs) in dietary compositions to assist in seizure management for companion animals.
Latest Patents
Among his latest patents, Jean-Christophe Bouthegourd focuses on compositions and methods comprising medium chain triglycerides for treating epilepsy. One of his notable inventions provides methods for treating epilepsy in companion animals by administering a food composition containing MCTs. This innovative approach has been designed to reduce or prevent seizures in pets. Moreover, he has developed a dietary regime aimed at enhancing the effects of anti-epileptic drugs (AEDs) in conjunction with MCTs, thereby improving treatment efficacy for animals suffering from epilepsy.
Career Highlights
Throughout his career, Jean-Christophe Bouthegourd has worked for prestigious companies, including Nestec S.A. and Société des Produits Nestlé S.A. His experience in these organizations has equipped him with the essential knowledge and skills to drive innovations that significantly impact animal health and wellness.
Collaborations
Jean-Christophe has collaborated with prominent individuals in his field, such as Yuanlong Pan and Brian Michael Zanghi. These collaborations have contributed to the development of his patented technologies, demonstrating the importance of teamwork in advancing veterinary medicinal practices.
Conclusion
With his innovative approach to treating epilepsy in companion animals, Jean-Christophe Bouthegourd continues to make a lasting impact in the veterinary field. His patents reflect a commitment to improving animal health and providing effective treatment options, showcasing the importance of innovation in addressing pressing medical issues.